Emergent BioSolutions Inc. is reshuffling leadership, consolidating certain functions and laying off about 5% of its workers in a bid to cut costs and focus on key business units. The Gaithersburg company said Monday it’s initiating an “organizational restructuring plan” that will position it to focus on its commercial and medical countermeasures products — its drugs and vaccines that protect against public health threats — as well as its contract development and manufacturing services.
Emergent BioSolutions initiates layoffs, leadership and structural changes to cut costs
January 10, 2023